Vitalibis, Inc. (VCBD)
OTCMKTS · Delayed Price · Currency is USD
0.0014
-0.0001 (-6.67%)
At close: Aug 28, 2025
Vitalibis Market Cap
Vitalibis has a market cap or net worth of $552.39 thousand as of August 29, 2025. Its market cap has increased by 931.10% in one year.
Market Cap
552.39K
Enterprise Value
n/a
Revenue
243.57K
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.00
Market Cap Chart
Since February 22, 2018, Vitalibis's market cap has decreased from 40.52M to 552.39K, a decrease of -98.64%. That is a compound annual growth rate of -43.52%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 28, 2025 | 552.39K | 1,497.11% |
| Dec 31, 2024 | 34.59K | -50.00% |
| Dec 27, 2023 | 69.17K | - |
| Dec 30, 2022 | 69.17K | 29.12% |
| Dec 31, 2021 | 53.57K | -87.54% |
| Dec 31, 2020 | 429.82K | -93.66% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Feb 22, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Nika Pharmaceuticals | 972.42M |
| Veradigm | 837.26M |
| Elite Pharmaceuticals | 705.48M |
| Tian'an Technology Group | 682.77M |
| Glass House Brands | 661.90M |
| Northwest Biotherapeutics | 443.96M |
| CytoDyn | 393.58M |
| American Oncology Network | 358.34M |